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The Bestrophinopathies are a group of inherited eye disorders that arise from either dominant or 
recessive mutations in the BEST1 gene. Electrooculography is invaluable in the diagnosis of Best 
disease (BD) and autosomal recessive bestrophinopathy (ARB), as a reduced Arden ratio is a highly 
penetrant feature of disease. We demonstrate that EOG phenotype in BD and ARB is more variable 







Normal Electrooculography in Best Disease and Autosomal Recessive Bestrophinopathy  
Abstract 
Purpose: To evaluate the electrooculogram (EOG) in a large series of patients with Best disease (BD) 
and autosomal recessive Bestrophinopathy (ARB). 
Methods:  A retrospective review of consecutive cases at Moorfields Eye Hospital, London, United 
Kingdom. Patients with BD or ARB who, after electrophysiological testing, had a normal or atypical 
EOG light rise were identified. Main outcome measure was EOG amplitude, clinical phenotype and 
genotype. 
Results: 113 patients were identified with likely disease-causing sequence variants in BEST1 (99 BD, 
14 ARB). EOGs had been performed in 75 patients. 20 patients (27%) had no detectable light rise 
(Arden ratio of 100%) and 49 (65%) had Arden ratios of between 100-165%. Six patients (8%) were 
found to have an EOG light rise of >165%. No cases demonstrated significant interocular asymmetry 
in EOG amplitude. 
Conclusions: The current work provides significant clinical evidence that the EOG phenotype in BD 
and ARB is more variable than currently appreciated. As a normal EOG may occur in the presence of 
a classical fundus appearance, the consequences of BEST1 mutation may be independently 
expressed, possibly mediated via differential effects on intracellular calcium homeostasis.  
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Normal Electrooculography in Best Disease and Autosomal Recessive Bestrophinopathy 
Introduction 
The Bestrophinopathies are a group of inherited eye disorders that arise from either dominant or 
recessive mutations in the BEST1 gene. The clinical spectrum of disorders include (i) diseases 
predominantly affecting the macula - Best disease (BD) and Adult Vitelliform Macular Dystrophy 
(AVMD); (ii) generalised retinal involvement - Autosomal Dominant Vitreoretinochoroidopathy 
(ADVIRC) and Retinitis Pigmentosa (RP); and (iii) diseases with retinal and anterior segment 
involvement – autosomal recessive Bestrophinopathy (ARB) and Microcornea, Rod-cone dystrophy, 
Cataract and posterior Staphyloma (MRCS).1-7 In addition to the phenotypic heterogeneity some of 
the bestrophinopathies display significant variation in penetrance of the clinical phenotype.8 
However, one endophenotype, the absent or reduced electrooculogram (EOG) light rise, is reported 
to be almost fully penetrant.9 This electrophysiological parameter arises as the cornea is positively 
charged relative to the negative retina thus creating a dipole through the eye that can be measured 
with surface electrodes. The light rise reflects a progressive depolarisation of the basal membrane of 
the retinal pigment epithelium (RPE) in response to a change from scotopic to photopic adaptation. 
Although the underlying molecular basis for the change in EOG with illumination is not known, it is 
almost always reduced in patients with BEST1 mutations. The present report investigates the EOG 
findings in a large cohort of patients with BD and ARB. 
 
Methods 
A retrospective review of the genetic database at Moorfields Eye Hospital, London, United Kingdom 
was undertaken to identify all patients with either bi-allelic or heterozygous mutations in BEST1 and 
a compatible clinical phenotype. Within this group only those who had undergone 
electrophysiological testing at our own institution were investigated further. Patients with a normal 
or atypical EOG light rise were then identified. 
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The EOG testing was performed to be consistent with ISCEV standards.10 Normative EOG data were 
obtained by testing 30 individuals aged between 30 and 60 years of age with no known ocular 
abnormalities. One eye from each normal subject was randomly selected and used to establish the 
normative data. In brief, EOG testing was performed with surface electrodes placed at the medial 
and lateral canthi of each eye. Thirty degree eye movements were recorded for 10 seconds of each 
minute during 15 minutes of dark adaptation, followed by a further 10–15 minutes in full-field 
(Ganzfeld) light adaptation (100 cd/m2). The amplitudes of the light peak and dark trough were 
directly measured and the light peak:dark trough ratio expressed as a percentage. Pattern 
electroretinograms (PERGs) and full-field ERGs (FFERGs) were used to assess macular function and 
generalised retinal function respectively.11, 12 All clinical electrophysiological assessments were 
analysed by one of two consultant electrophysiologists (GH or AR) masked to the molecular 
diagnosis. 
 
A clinical diagnosis was made based on the fundoscopic appearance together with findings on 
optical coherence tomography (OCT) and fundus autofluorescence (FAF) (excitation wavelength 488 
nm; Spectralis, Heidelberg Engineering, Heidelberg, Germany). A genetic diagnosis was determined 
by DNA sequencing (Manchester Regional Genetics Laboratory).  Genomic DNA was extracted from 
peripheral blood (Qiagen Blood DNA extraction kit, Qiagen, Crawley, UK) and used as the template 
for bidirectional Sanger sequencing analysis of the entire coding regions of BEST1, including the 
splice donor and acceptor sites. 
 
Results 
The EOG Arden ratios in the normal subjects ranged from 180% to 435% (median 267%, SD 50% 
n=30). For this study we considered an Arden ratio of less than 165% to be abnormal (2SD below the 
mean).  
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A total of 113 patients were identified with likely disease-causing sequence variants in BEST1 (99 BD, 
14 ARB). Electrophysiological testing had been performed in 75 patients. Three groups were 
identified. 20 patients (27%) had no detectable light rise (Arden ratio of 100%), whilst 49 cases (65%) 
had Arden ratios of between 100-165%. Six patients (8%) were found to have an EOG light rise of 
>165% and will be described in detail below. No cases were identified with sufficient asymmetry in 
Arden ratios to cause eyes of the same patient to be categorised differently. 
Patient 1 was diagnosed with BD aged 8 based on bilateral typical macular vitelliform lesions. He 
later presented with reduced vision in his right eye due to macular scarring from a presumed occult 
choroidal neovascular membrane and underwent EOG testing aged 39. Arden ratios were 220% right 
and 180% left. FFERGs were normal and symmetrical, indicating no evidence of generalised retinal 
dysfunction. PERG P50 component was mildly subnormal on the right consistent with mild right 
macular dysfunction. The diagnosis of BD was thereby questioned and PRPH2 gene screening was 
initiated but no pathogenic variants were identified. BEST1 screening revealed a heterozygous 
missense amino-acid substitution (p.Arg25Trp) previously associated with BD.13 
Patient 2 was diagnosed with BD as a teenager when her vision deteriorated in both eyes. The 
diagnosis was questioned when she was seen between the ages of 28-36 due to an atypical macular 
appearance.  OCT imaging demonstrated focal choroidal excavation alongside subretinal deposit and 
fluid. The FFERG was normal, but the PERG P50 component was reduced, left more than right in 
keeping with macular dysfunction. Eye movement artefacts disrupted accurate grading of the EOG 
but an adequate light rise and dark trough were noted, consequently this patient was reported to 
have a normal EOG and included in this cohort. Screening BEST1 identified the variant p.Lys30Asn, 
predicted to be damaging as this residue is highly conserved (PolyPhen2 score 1.0). Although the 
EOG was reported as normal, accurate quantification of the Arden ratio had not been possible. As 
part of this study the EOG was then repeated 12 months later, this time a reduced light rise with an 
Arden index of 120% in each eye was recorded, consistent with the diagnosis of BD. 
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Patient 3 was diagnosed in his youth with a macular dystrophy that resembled BD. He was part of a 
consanguineous pedigree with a similarly affected brother living abroad. When he was examined 
aged 41 the right macula was found to be atrophic and the left showed subfoveal fluid and 
subretinal deposit (Figure 1). The EOG light rise to dark trough ratio was 175% on the right and 260% 
on the left.  The PERG P50 component was bilaterally subnormal in keeping with macular 
dysfunction. FFERGs were normal. BEST1 gene screening identified the homozygous variant 
p.Arg47Cys, previously shown to cause ARB, also with a vitelliform rather than multifocal 
phenotype.14, 15 
Patient 4 was diagnosed with BD aged 9 based on a vitelliform maculopathy and dominant family 
history. The EOG light rise to dark trough ratio was 180% bilaterally. There was PERG evidence of 
mild left macular dysfunction. FFERGs were normal bilaterally. Screening of BEST1 revealed a 
previously reported heterozygous mutation p.Tyr85His.16  
Patient 5 was diagnosed in childhood with BD and was examined again at the age of 33. She had a 
small vitelliform lesion in her right eye and a petaloid arrangement of subretinal deposit in her left 
eye in keeping with a reticular pattern dystrophy-like phenotype. No similarly affected family 
members were known. The FFERG and PERG were normal and her EOG light rise to dark trough ratio 
was 175% on the right and 180% on the left. DNA sequencing identified a BEST1 variant 
(p.Ala243Val) already known to cause disease BD.3 
Patient 6 had a history of poor vision from the age of 12 and was found to be hyperopic at the age of 
20 years old. His left eye was amblyopic. Both his parents had good vision into their seventh decade. 
By the age of 37 his vision had declined to hand movement in the right eye and 1/60 in the left eye. 
He was diagnosed with BD after retinal examination revealed a vitelliform maculopathy in his right 
eye and well defined atrophy in the left (Figure 2). The FFERG was normal, but the PERG was 
reduced. The EOG light rise was recorded at 200% in each eye. Screening the genes PRPH2 and 
BEST1 identified p.Leu567Phe in BEST1 as the only likely pathological variant. This variant has been 
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previously reported as a possible cause of late adulthood onset retinal dystrophy and theoretically is 
sufficiently rare to cause BD, (0/61730511, Exome Aggregation Consortium (ExAC) database.17,18 As it 
remains questionable whether this variant accounts for the maculopathy present in Patient 6, whole 
genome sequencing is being employed to elucidate the genetic cause. 
Discussion 
In this cohort of patients with molecularly proven BD or ARB, four individuals (5.4%) were found to 
have a normal, or greater EOG light rise than usually seen in the bestrophinopathies. This was a 
higher number than expected, as although BEST1 mutations are associated with varied expression of 
the fundus phenotype, it is considered a rarity that the EOG light rise remains unaffected, with only 
a few individual cases reported.3, 13-15, 19-24 The present findings, when combined with published data, 
demonstrate that of the 269 unique BEST1 mutations thus far collated, at least 3.3% have now been 
associated with a greater than expected EOG amplitude (Table 1).25  
In collecting these data we are able to highlight two potential reasons whereby erroneous 
conclusions may be made when interpreting the results of either electrophysiological or genetic 
testing. Firstly, inaccurate saccadic eye movements in Patient 2 produced the illusion of a falsely high 
Arden ratio. This was noticed by careful review of the traces and corrected by retesting. Secondly, 
pathogenicity has probably been wrongly assigned to the variant p.Leu567Phe identified in Patient 6; 
given that it has only been seen twice before (and only in the context of age-related macular 
degeneration), is not a highly conserved residue, and when modelled in vitro does not alter chloride 
conductance or channel permeability to anions.26, 27 This case highlights the increasing challenge that 
is faced in definitively ascribing disease-causation to identified sequence variants, especially for 
missense mutations. 
Why a subgroup of patients retain a light rise is currently unknown. Theoretically it is possible that 
they represent a group who, in the absence of a mutation, would have recorded an unusually high 
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light rise. Therefore, whilst the effects of mutation result in a reduction of amplitude, this only 
serves to bring it to the lower end of the normal range. Data derived from testing normal individuals 
herein shows a more than two fold difference between the lowest and highest Arden ratios (180-
435%) and the authors do have experience of at least one normal subject with a light rise of more 
than 500% (unpublished data). Given these findings, it is likely that genetic modifiers exist which 
may influence the EOG amplitude, either via effects on BEST1 itself or interacting proteins. One 
hypothesis, that may also underpin the variation in fundus expression, proposes that a normal EOG 
may result from relatively higher expression of the wild-type compared to mutant allele. Whilst 
allelic imbalance is a plausible explanation for dominant disease, it would be harder to argue in cases 
of recessive inheritance, where the ability to maintain a light rise must depend upon presence of 
some retained BEST1 function. Recessive alleles are thought to be functionally null, however this 
may not always be the case. The p.Arg47Cys mutation (patient 3 in our series) has now occurred 
with relatively mild EOG on three independent occasions and in different ethnic populations.14, 15 An 
additional atypical finding in these cases is the presence of unifocal disease, as recessive disease is 
usually more widespread. It is possible that these alleles are hypomorphic and retain sufficient 
function to support anion transport across the basolateral surface of the RPE thus maintaining an 
EOG light rise, and at the same time have enough function to limit the disease to the macula. The 
same mechanism may also be proposed for the recessive c.1100+1G>A allele, suggesting that 
aberrant spicing does affect all transcripts.24 
Interestingly, all the mutations that have been associated with a normal EOG have also been 
described in individuals with a poor or absent light rise on EOG. This variability has been observed in 
members of the same family, again suggesting the influence of genetic or environmental modifiers.23 
Some variants however are overrepresented within the normal EOG group, particularly the 
p.Ala243Val mutation. Out of 42 unique heterozygous mutations identified in this cohort, 
p.Ala243Val was the second most commonly reported (n=6), the most prevalent being p.Arg218Cys 
(n=10). Whilst this could suggest that the association with a normal EOG is a chance finding, others 
 10 
have also reported this genotype with a normal Arden ratio (Table 1). If chance alone were acting 
one would expect that the most commonly encountered mutation (p.Arg218Cys) would be most 
often associated with a normal Arden ratio. This has only been described once before and in our 
series this genotype always had an abnormal EOG.19 The ability to generate a light rise therefore may 
in some cases be strongly influenced by the genotype (p.Arg47Cys, p.Ala234Val) whilst other factors, 
yet to be determined, are responsible for the remainder.  
Whilst the molecular basis supporting the light rise of the EOG has yet to be established, our 
understanding of conditions that may alter it has advanced. The polarised RPE is thought to generate 
and maintain a potential difference across its surface, and this can be affected in both health and 
disease.28-30 In the presence of light, the conduction of anions across the basolateral RPE membrane 
is thought to increase, resulting in depolarisation and a rise in the recorded potential difference. This 
process may be pharmacologically manipulated, as lamotrigine and acetazolamide have both been 
shown to reduce the amplitude of the EOG light rise.31-33 Additionally, the stimulus for the light rise 
does not need to be photic, as alcohol (supplied by the choroidal circulation) simulates this 
phenomenon.30 In the disease state, the RPE may either not be able to maintain its polar properties 
due to disorganisation of tight junctions, or may not be able to pump anions efficiently or as 
normally directed. This is the supposition in cases of BD and in some cases of acute zonal occult 
outer retinopathy (AZOOR) in which the EOG is severely affected.34  
In order to gain a better understanding of the underlying pathology, Singh et al. generated an 
induced pluripotent stem cell (iPS) model for BD.35 Initially, RPE cells derived from patients with BD 
showed no differences from control iPS-RPE cells, however after exposure to a stressor, BD iPS-RPE 
cells demonstrated reduced phagocytosis and accumulation of autofluorescent material.35 Although 
in vivo all RPE cells should be equally susceptible to the effects of mutation, it may be that only RPE 
cells responsible for maintaining the foveal photoreceptors are sufficiently stressed to demonstrate 
functional abnormalities, as subretinal deposit rarely accumulates outside the macula in BD. As both 
 11 
the amplitude of the light rise and the presence of maculopathy can be individually and 
independently expressed, the underlying mechanisms may be divergent. The processes responsible 
for generating the EOG are less likely to involve the phagocytic pathway but may be calcium 
dependant, as BD iPS-RPE cells exhibit altered endoplasmic reticulum (ER) dependent calcium 
currents when compared to control cells.35, 36 Indeed it has been suggested that the RPE acting alone 
can respond to photic stimulation, generating an increase in inositol triphosphate (IP3), resulting in 
calcium release from the ER into the cytosol, followed by transport of chloride ions across the 
basolateral RPE membrane.37 Restoration of intracellular calcium levels is thought to require both L-
type calcium channels as well as BEST1, acting to transport chloride as a counter ion.38 
Recently it has been suggested that there is a dynamic relationship in the distance between the 
photoreceptor outer segment (POS) and the inner surface of the RPE, so called “outer segment 
equivalent length” (OSEL), such that in light the two are closely approximated whereas in the dark 
they lay further apart.39 Abramoff et al. suggest that these morphological changes have a similar 
time course to the EOG changes in light and dark; and that these changes are abolished, and even 
reversed in patients with BD and an abnormal EOG, where there is chronic OSEL lengthening rather 
than shortening in response to light.39 They suggest that one role of BEST1 is to enable the 
approximation of the RPE and photoreceptor outer segment thus enhancing the efficiency of 
phagocytosis. We now propose an alternative hypothesis, that BEST1 facilitates pigment granule 
migration within the RPE. In the dark-adapted state Johnson et al. have shown that these granules 
aggregate towards the base of the cell.40 Under such conditions OCT measurement of OSEL would 
represent the distance from the ellipsoid zone to the lower half of the RPE (where the pigment 
granules reside). In the light the granules disperse, mediated by a calcium dependant mechanism, 
and now preferentially reside within the apical processes of the RPE.40 The OSEL would now be 
correspondingly shorter, and this shortening would be determined by pigment migration rather than 
the length of the photoreceptor outer segment. In BD, dysfunctional BEST1 protein within the ER 
would disrupt normal calcium homeostasis, resulting in less pigment dispersion and reduced 
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migration to the apical processes.40 Accordingly the OSEL would not be expected to reduce in BD as 
observed in the original study.39  
BEST1 function is therefore thought to be critical for multiple but independent cellular processes, 
probably indirectly mediated by its ability to regulate intracellular calcium levels. The effects of 
mutation are correspondingly diverse. Firstly, it can reduce light induced chloride efflux at the 
basolateral surface of the RPE (most likely through TMEM16A calcium gated chloride channels), as 
mutant BEST1 channels may result in reduced ER calcium stores. If these stores are replenished 
through a different pathway, chloride efflux may still be supported and an EOG light rise may be 
generated. Secondly, BEST1 mutation can reduce POS phagocytosis, a process similarly controlled by 
intracellular calcium. Thirdly, altered pigment granule migration is thought to be calcium dependant, 
and is worthy of further investigation as a novel endophenotype in BD. The current work now 
provides clinical evidence that the EOG phenotype is more variable than once thought. As the 
calcium sensitive chloride channels, phagocytic process and pigment granule migration pathways are 
all likely to have differential calcium sensitivities, it is perhaps not surprising that patients with BEST1 
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Figure 1. Multimodal imaging in Patient 3 with molecularly proven autosomal recessive 
betrophinopathy (ARB). (A) Near infra-red reflectance imaging demonstrating central macular 
lesions. (B) 50° 488nm fundus autofluorescence imaging highlights the absence of extra-macular 
disease, which is usually a typical feature of ARB, and macular lesions at different stages of disease. 
(C) Optical coherence tomography shows well-defined outer retinal atrophy in the right eye and an 
earlier stage of disease characterised by subretinal fluid in the left eye. Another feature of ARB, 
intraretinal fluid is notably absent.  
Figure 2. Multimodal imaging of Patient 6 over two years showing features typically associated with 
Best Disease. (A) Near infra-red reflectance imaging identifies focal central macular lesions in both 
eyes. (B) 488nm fundus autofluorescence imaging highlights an initial uniform increase in signal at 
the right macula, which later becomes more heterogeneously distributed, possibly under the 
influence of gravity, and a lack of physiological autofluorescence from the left eye. (C) Optical 
coherence tomography is helpful in demonstrating the subretinal location of the vitelliform material 
in the right eye, and the extent of outer retinal atrophy in the left eye. 
Table 1. A summary of all known BEST1 variants which are associated with a higher than expected 
Arden ratio. The data is ordered based on the position of the mutant residue. The current work 
(Patients 1, 3, 4 and 5) is presented alongside previously reported studies. In all cases testing 
incorporated the relevant ISCEV standards of the time.   
